| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |